Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Cancer Immunology, Immunotherapy : CII|November 12, 2010
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findingsStéphane Oudard, Olivier Rixe, Benoit Beuselinck, et al.
International Journal of Molecular Sciences|June 19, 2024
Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate CancerEmmanuel Chamorey, Marc Pujalte-Martin, Jean-Marc Ferrero, et al.
Clinical Genitourinary Cancer|August 27, 2023
Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG-AFU 26 NIVORENGuillemette Guilhem-Ducléon, Cécile Dalban, Sylvie Negrier, et al.
BJU International|November 5, 2013
Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 studyFlorence Joly, Remy Delva, Loïc Mourey, et al.
Bulletin Du Cancer|January 7, 2004
[Standards, Options and Recommendations 2002 for the management of adult patients with intracranial gliomas (summary report)]Didier Frappaz, Olivier Chinot, Anne Bataillard, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2015
Trabectedin in patients with advanced soft tissue sarcoma: a retrospective national analysis of the French Sarcoma GroupAxel Le Cesne, Isabelle Ray-Coquard, Florence Duffaud, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2024
PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohortJérémie Naffrichoux, Pierre Poupin, William Pouillot, et al.
The Lancet. Oncology|December 3, 2014
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trialKarim Fizazi, Lance Pagliaro, Agnes Laplanche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT TrialLaetitia Mauge, Arnaud Mejean, Laure Fournier, et al.
Journal of Adolescent and Young Adult Oncology|November 9, 2019
Methotrexate-Etoposide-Ifosfamide Compared with Doxorubicin-Cisplatin-Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18-25 YearsPerrine Marec-Berard, Valérie Laurence, Bob-Valéry Occean, et al.
Pageof 5